Qualitek Labs (QLL) | Stock Overview & Key Data
Qualitek Labs Performance Comparison
Stock Range
Today's Range
Low: ₹314.35
High: ₹339.35
on August 22, 2025
52 Week Range
Low: ₹215.05
High: ₹375.00
on March 5, 2025
on December 27, 2024
All-Time High: ₹375.00 on December 23, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR3.2B
EPS
7.07
P/E Ratio (TTM)
45.40
Forward P/E
N/A
P/B Ratio
3.29
PEG Ratio
N/A
Div. Yield
N/A
ROE
12.27%
Beta
N/A
Debt to Equity
37.74
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
20.77%
Profit Margin
8.97%
Returns and Earnings
Return on Assets (TTM)
7.19%
Return on Equity (TTM)
12.27%
EBITDA
INR167.6M
Net Income (TTM)
INR63.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR70.37
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Qualitek Labs QLL | 3.20B Small-cap | 3.21% | 4.58% | 2.40% | 36.93% | -10.04% | -1.65% | 113.18% | 113.18% |
| Dr. Lal PathLabs LALPATHLAB | 287.98B Large-cap | -1.57% | 12.35% | 19.67% | 30.32% | 10.54% | 2.15% | 28.00% | 83.35% |
| Syngene SYNGENE | 268.17B Large-cap | 0.57% | -1.27% | 5.09% | -4.77% | -24.09% | -20.79% | 11.22% | 36.75% |
| Vimta Labs VIMTALABS | 31.52B Small-cap | -0.96% | 26.84% | 33.57% | 41.42% | 33.04% | 144.79% | 246.88% | 1,080.88% |
| Krsnaa Diagnostics KRSNAA | 26.80B Small-cap | -2.03% | -5.30% | 25.27% | 10.14% | -11.16% | 11.80% | 69.40% | -12.70% |
| Suraksha Diagnostic SURAKSHA | 16.60B Small-cap | 0.03% | 0.21% | -3.07% | 7.14% | -17.32% | -24.69% | -24.69% | -24.69% |
Ownership & Short Interest
Insider Ownership
69.27%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
8K
Average 90-Day Volume
7K
Qualitek Labs Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Qualitek Labs would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is QLL's 52-week high and low?
- In the last 52 weeks, Qualitek Labs reached a high of ₹375.00 (on December 27, 2024) and a low of ₹215.05 (on March 5, 2025).
- What is the market cap and P/E ratio for QLL?
- Curious about Qualitek Labs's size and valuation? Its market capitalization stands at 3.20B. When it comes to valuation, the P/E ratio (trailing twelve months) is 45.40, and the forward P/E (looking ahead) is N/A.
- Does QLL pay dividends? If so, what's the yield?
- As for dividends, Qualitek Labs isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Qualitek Labs's main competitors or similar companies to consider before investing?
When looking at Qualitek Labs, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Dr. Lal PathLabs
LALPATHLAB287.98B Healthcare Diagnostics & Research 2.15% 28.00% Syngene
SYNGENE268.17B Healthcare Diagnostics & Research -20.79% 11.22% Vimta Labs
VIMTALABS31.52B Healthcare Diagnostics & Research 144.79% 246.88% Krsnaa Diagnostics
KRSNAA26.80B Healthcare Diagnostics & Research 11.80% 69.40% Suraksha Diagnostic
SURAKSHA16.60B Healthcare Diagnostics & Research -24.69% -24.69% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Qualitek Labs Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Qualitek Labs's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.27%, the Debt to Equity ratio from the most recent quarter is 37.74, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for QLL?
- Looking at Qualitek Labs's growth, its revenue over the trailing twelve months (TTM) was INR702M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of QLL stock is held by insiders and institutions?
- Wondering who owns Qualitek Labs stock? Company insiders (like executives and directors) hold about 69.27% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.